News

FDA approves Rhapsido (remibrutinib) for symptomatic dermographism, the first prescription treatment for adults with the condition inadequately controlled by...

AI deployment in clinical studies requires validation framework and governance structure to address compliance gaps and enable safe implementation.

CRScube and Mednet demonstrate integration-free EHR-to-EDC tool designed to reduce manual transcription errors and streamline clinical data capture.

Oculis to present licaminlimab data at AAO 2026 following year-end PREDICT-1 readout in genotype-selected dry eye patients.

Rezdiffra shows consistent efficacy across common MASH genetic risk variants in Phase 3 analysis, addressing prescribing concerns for high-risk...

Enfortumab vedotin-pembrolizumab shows durability advantage over chemotherapy at three-year follow-up in bladder cancer trial EV-302.

Regeneron will present updated C-POST overall survival data for adjuvant cemiplimab in high-risk CSCC at ESMO 2026 on October...

Headlands Research Portland site marks 50 years of continuous Alzheimer's trials, contributing to every FDA-approved medication class since 1993.

Advarra's IRB chief targets pre-review delays as the next efficiency frontier to reduce waiting time for researchers and trial...

Forward Therapeutics' FT2109 advances to Phase 2 after clearing Phase 1 with once-daily oral dosing and a supportive safety...